RESTON, Va., Feb. 27, 2017 /PRNewswire/ -- Leidos (NYSE: LDOS), a global science and technology company, announced they have been included in the 2017 Best in KLAS Awards: Professional Services (©2017 KLAS Enterprises, LLC. All rights reserved). KLAS publishes the annual report to help improve service delivery, by independently measuring vendor performance for the benefit of healthcare provider partners, consultants, investors, and vendors.
In the latest Best in KLAS report, Leidos Health ranked as a leader in the Technical Services category with an overall score of 96.9, outperforming others in the industry. In addition, the company rated highly in the Sales & Contracting, Services & Support and Implementation & Training performance categories.
"It is truly an honor to be included in The Best in KLAS report – a true benchmark for the industry," said Tom Aikens, senior vice president Leidos Commercial Health. "Our placement in the report reinforces our commitment to providing the best services and support for our customers."
KLAS is a research firm specializing in monitoring and reporting the performance of healthcare vendors. KLAS' mission is to improve delivery, by independently measuring vendor performance for the benefit of our healthcare provider partners, consultants, investors, and vendors. For more information about KLAS, visit www.KLASresearch.com.
Leidos is a global science and technology solutions leader working to solve the world's toughest challenges in the defense, intelligence, homeland security, civil, and health markets. The company's 32,000 employees support vital missions for government and commercial customers. Headquartered in Reston, Virginia, Leidos reported annual revenues of approximately $7.04 billion for the fiscal year ended December 30, 2016. For more information, visit www.Leidos.com.
Statements in this announcement, other than historical data and information, constitute forward-looking statements that involve risks and uncertainties. A number of factors could cause our actual results, performance, achievements, or industry results to be very different from the results, performance, or achievements expressed or implied by such forward-looking statements. Some of these factors include, but are not limited to, the risk factors set forth in the company's Annual Report on Form 10-K for the period ended January 1, 2016, and other such filings that Leidos makes with the SEC from time to time. Due to such uncertainties and risks, readers are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date hereof.